# A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-meta-analysis-the-clinical-value-of-pd-1-inhibitor-or-protein-tyrosine-kinase/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Binhao Shi,Junli Chang,Xingyuan Sun,Xiaoping Ma,Peng Zhao,Chujie Zhou,Yongjun Wang,Yanping Yang |
| Citations | 10 |
| DOI | 10.3389/fonc.2023.1148735 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fonc.2023.1148735/pdf |
| OpenAlex ID | https://openalex.org/W4380264687 |
| PMID | 37377920 |
| Type | review |
| Year | 2023 |

## Paper authors

- [Peng Zhao](https://scholariq.org/researchers/peng-zhao/)

## Paper journal

- [Frontiers in Oncology](https://scholariq.org/journals/frontiers-in-oncology/)

## Paper primary topic

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)

## Paper topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.